These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16498394)

  • 21. Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes.
    Mathis S; Chapuis N; Debord C; Rouquette A; Radford-Weiss I; Park S; Dreyfus F; Lacombe C; Béné MC; Kosmider O; Fontenay M; Bardet V
    Leukemia; 2013 Oct; 27(10):1981-7. PubMed ID: 23765225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD36 relative mean fluorescence intensity of CD105
    Lu Y; Chen X; Zhang L
    Sci Rep; 2023 Jun; 13(1):8930. PubMed ID: 37264109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rescue of early-stage myelodysplastic syndrome-deriving erythroid precursors by the ectopic expression of a dominant-negative form of FADD.
    Claessens YE; Park S; Dubart-Kupperschmitt A; Mariot V; Garrido C; Chrétien S; Dreyfus F; Lacombe C; Mayeux P; Fontenay M
    Blood; 2005 May; 105(10):4035-42. PubMed ID: 15677568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expression of differentiation antigens on bone marrow myeloid cells of the patients with myelodysplastic syndromes and its clinical significances].
    Li LJ; Fu R; Wang HQ; Yue LZ; Liu H; Wang J; Wang HL; Ruan EB; Qu W; Liang Y; Wang GJ; Wang XM; Liu H; Song J; Wu YH; Xing LM; Guan J; Shao ZH
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(10):672-7. PubMed ID: 20450725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative multi-color flow cytometric analysis of cell surface antigens in bone marrow hematopoietic progenitors between refractory anemia and aplastic anemia.
    Otawa M; Kawanishi Y; Iwase O; Shoji N; Miyazawa K; Ohyashiki K
    Leuk Res; 2000 Apr; 24(4):359-66. PubMed ID: 10713334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired Mitophagy of Nucleated Erythroid Cells Leads to Anemia in Patients with Myelodysplastic Syndromes.
    Jiang H; Yang L; Guo L; Cui N; Zhang G; Liu C; Xing L; Shao Z; Wang H
    Oxid Med Cell Longev; 2018; 2018():6328051. PubMed ID: 29967662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Changes of CD34(+) and CD71(+)CD45(-) cell levels in bone marrow of MDS and AA patients].
    Yan ZY; Tian X; Li Y; Yang MR; Zhang S; Wang XM; Zhang HX; Cheng NY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):382-6. PubMed ID: 24763009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Side scatter ratio of the CD105-positive and CD105-negative red blood cell fractions is useful for the detection of low-grade myelodysplastic neoplasms by flow cytometry.
    Wang Z; Ciarlini PC; Oduro KA; Gadde R; O'Neill S; Zhao C; Meyerson HJ
    Am J Clin Pathol; 2024 Aug; 162(2):191-201. PubMed ID: 38581145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive phenotyping of erythropoiesis in human bone marrow: Evaluation of normal and ineffective erythropoiesis.
    Yan H; Ali A; Blanc L; Narla A; Lane JM; Gao E; Papoin J; Hale J; Hillyer CD; Taylor N; Gallagher PG; Raza A; Kinet S; Mohandas N
    Am J Hematol; 2021 Sep; 96(9):1064-1076. PubMed ID: 34021930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD71 (transferrin receptor): an effective marker for erythroid precursors in bone marrow biopsy specimens.
    Marsee DK; Pinkus GS; Yu H
    Am J Clin Pathol; 2010 Sep; 134(3):429-35. PubMed ID: 20716799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dyserythropoiesis of myelodysplastic syndromes.
    Lefèvre C; Bondu S; Le Goff S; Kosmider O; Fontenay M
    Curr Opin Hematol; 2017 May; 24(3):191-197. PubMed ID: 28072603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Qualitative flow cytometric analysis of Malaysian myelodysplastic syndromes (MDS) patients.
    Mohadese Hashem B; Rajesh R; Sabariah MN; Zainina BS
    Med J Malaysia; 2012 Feb; 67(1):77-80. PubMed ID: 22582553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-Grade Myelodysplastic Syndromes with Preserved CD34+ B-Cell Precursors (CD34+ Hematogones).
    Chen Z; Ok CY; Wang W; Goswami M; Tang G; Routbort M; Jorgensen JL; Medeiros LJ; Wang SA
    Cytometry B Clin Cytom; 2020 Jan; 98(1):36-42. PubMed ID: 31211490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD43 and CD49d from the B-Cell Chronic Lymphoproliferative Disorders Diagnostic Panel Are Useful to Detect Erythroid Dysplasia.
    Oliveira M; Laranjeira P; Fortuna M; Bártolo R; Ribeiro A; Santos M; Cortesão E; Marques G; Sarmento-Ribeiro AB; Vitória H; Ribeiro L; Paiva A
    Cytometry B Clin Cytom; 2019 Sep; 96(5):417-425. PubMed ID: 31157955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic significance of flow cytometry scales in diagnostics of myelodysplastic syndromes.
    Davydova YO; Parovichnikova EN; Galtseva IV; Kokhno AV; Dvirnyk VN; Kovrigina AM; Obukhova TN; Kapranov NM; Nikiforova KA; Glinkina SA; Troitskaya VV; Mikhailova EA; Fidarova ZT; Moiseeva TN; Lukina EA; Tsvetaeva NV; Nikulina OF; Kuzmina LA; Savchenko VG
    Cytometry B Clin Cytom; 2021 May; 100(3):312-321. PubMed ID: 33052634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromes.
    Senent L; Arenillas L; Luño E; Ruiz JC; Sanz G; Florensa L
    Haematologica; 2013 Apr; 98(4):568-75. PubMed ID: 23065505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry.
    van de Loosdrecht AA; Westers TM; Westra AH; Dräger AM; van der Velden VH; Ossenkoppele GJ
    Blood; 2008 Feb; 111(3):1067-77. PubMed ID: 17971483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myelodysplastic syndrome: validation of flow cytometry multilineage score system.
    Araújo HV; Correia RP; Bento LC; Vaz ADC; Sousa FA; Alexandre AM; Schimidell D; Pedro EC; Ioshida MR; Barroso RS; Bacal NS
    Einstein (Sao Paulo); 2020; 18():eAO4966. PubMed ID: 31994605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proliferation and differentiation of myelodysplastic CD34+ cells: phenotypic subpopulations of marrow CD34+ cells.
    Sawada K; Sato N; Notoya A; Tarumi T; Hirayama S; Takano H; Koizumi K; Yasukouchi T; Yamaguchi M; Koike T
    Blood; 1995 Jan; 85(1):194-202. PubMed ID: 7528567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Granulocyte colony-stimulating factor inhibits spontaneous cytochrome c release and mitochondria-dependent apoptosis of myelodysplastic syndrome hematopoietic progenitors.
    Tehranchi R; Fadeel B; Forsblom AM; Christensson B; Samuelsson J; Zhivotovsky B; Hellstrom-Lindberg E
    Blood; 2003 Feb; 101(3):1080-6. PubMed ID: 12393561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.